Blue Rock Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$375K Hold
1,515
0.21% 69
2026
Q1
$325K Hold
1,515
0.21% 72
2025
Q4
$341K Sell
1,515
-50
-3% -$11.4K 0.21% 72
2025
Q3
$357K Buy
1,565
+252
+19% +$51.3K 0.22% 68
2025
Q2
$241K Sell
1,313
-65
-5% -$12.1K 0.17% 87
2025
Q1
$285K Buy
+1,378
New +$268K 0.24% 74

Other funds holding ABBV

Blue Rock Wealth Management's ABBV Position: Q2 2026 in Review

Blue Rock Wealth Management held its AbbVie (ABBV) position steady in Q2 2026 at 1,515 shares worth $375K. The position accounts for 0.21% of the portfolio, ranked #69.

Blue Rock Wealth Management first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 2,236 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Blue Rock Wealth Management held 1,515 shares of AbbVie worth $375K as of Q2 2026.
  • Blue Rock Wealth Management left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.21% of Blue Rock Wealth Management's portfolio in Q2 2026, its #69 holding.
  • Blue Rock Wealth Management first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • 2,236 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Blue Rock Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.